Gust K - Search Results

1

Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3).

Hautmann RE, Volkmer BG, Gust K. Hautmann RE, et al. Among authors: gust k. World J Urol. 2009 Jun;27(3):347-51. doi: 10.1007/s00345-009-0402-4. Epub 2009 Mar 25. World J Urol. 2009. PMID: 19319539

2

[GreenLight laser therapy for benign prostatic hyperplasia: dilemma of reimbursement in the DRG system].

Petschl S, Finter F, Gust K, Volkmer BG. Petschl S, et al. Among authors: gust k. Urologe A. 2009 Feb;48(2):177-82. doi: 10.1007/s00120-008-1885-0. Urologe A. 2009. PMID: 18931990 German.

3

Oncological followup after radical cystectomy for bladder cancer-is there any benefit?

Volkmer BG, Kuefer R, Bartsch GC Jr, Gust K, Hautmann RE. Volkmer BG, et al. Among authors: gust k. J Urol. 2009 Apr;181(4):1587-93; discussion 1593. doi: 10.1016/j.juro.2008.11.112. Epub 2009 Feb 23. J Urol. 2009. PMID: 19233433

4

[Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].

Rinnab L, Gust K, Hautmann RE, Küfer R. Rinnab L, et al. Among authors: gust k. Urologe A. 2009 May;48(5):516-22. doi: 10.1007/s00120-009-1954-z. Urologe A. 2009. PMID: 19296069 Review. German.

5

Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?

Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE. Volkmer BG, et al. Among authors: gust k. J Urol. 2009 Dec;182(6):2632-7. doi: 10.1016/j.juro.2009.08.046. J Urol. 2009. PMID: 19836794

6

The feasibility of ureteral tissue engineering using autologous veins: an orthotopic animal model with long term results.

Engel O, de Petriconi R, Volkmer BG, Gust KM, Mani J, Haferkamp A, Hautmann RE, Bartsch G. Engel O, et al. J Negat Results Biomed. 2014 Nov 8;13:17. doi: 10.1186/1477-5751-13-17. J Negat Results Biomed. 2014. PMID: 25381044 Free PMC article.

7

Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.

Soria F, Moschini M, Wirth GJ, Gust KM, Klatte T, Briganti A, Gontero P, Abufaraj M, Özsoy M, Karakiewicz PI, Shariat SF. Soria F, et al. Urology. 2017 Aug;106:119-124. doi: 10.1016/j.urology.2017.04.049. Epub 2017 May 12. Urology. 2017. PMID: 28506860

8

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.

Soria F, Droller MJ, Lotan Y, Gontero P, D'Andrea D, Gust KM, Rouprêt M, Babjuk M, Palou J, Shariat SF. Soria F, et al. World J Urol. 2018 Dec;36(12):1981-1995. doi: 10.1007/s00345-018-2380-x. Epub 2018 Jun 21. World J Urol. 2018. PMID: 29931526 Free PMC article. Review.

9

Molecularly-driven precision medicine for advanced bladder cancer.

Krabbe LM, Margulis V, Schrader AJ, Shariat SF, Gust KM, Boegemann M. Krabbe LM, et al. World J Urol. 2018 Nov;36(11):1749-1757. doi: 10.1007/s00345-018-2354-z. Epub 2018 Jun 8. World J Urol. 2018. PMID: 29948043 Review.

10

Molecular markers in bladder cancer.

Soria F, Krabbe LM, Todenhöfer T, Dobruch J, Mitra AP, Inman BA, Gust KM, Lotan Y, Shariat SF. Soria F, et al. World J Urol. 2019 Jan;37(1):31-40. doi: 10.1007/s00345-018-2503-4. Epub 2018 Sep 26. World J Urol. 2019. PMID: 30259123 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters